Scott Whitaker sent a letter to HHS calling for staff cuts at the FDA to be reversed, arguing patient care and U.S.
Harmony Biosciences is facing more of a nightmare than sweet dreams on the road to securing a new use for its excessive ...
Harmony Biosciences' (NASDAQ:HRMY) stock fell about 7.3% after U.S. FDA notified the company that it will not review the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback